T-cell vaccination in the treatment of HIV infection
    1.
    发明申请
    T-cell vaccination in the treatment of HIV infection 失效
    T细胞疫苗接种治疗艾滋病毒感染

    公开(公告)号:US20070122877A1

    公开(公告)日:2007-05-31

    申请号:US11290682

    申请日:2005-11-30

    IPC分类号: C12Q1/68 C12P21/06

    摘要: A method for the preparation of a T cell vaccine for the treatment of immunodeficient HIV-infected patients is described herein, based on the enrichment of autologous CD4-reactive CD8 T cells. Also described is a protocol for the implementation of T cell vaccination in immunodeficient HIV-infected, as well as a method of treatment, based on the T cell vaccine developed herein. Finally, kits for preparing the T cell vaccine as well as for implementing the protocol are also provided.

    摘要翻译: 基于自体CD4反应性CD8T细胞的富集,本文描述了用于制备用于治疗免疫缺陷型HIV感染患者的T细胞疫苗的方法。 还描述了用于在免疫缺陷型HIV感染中实施T细胞疫苗接种的方案,以及基于本文开发的T细胞疫苗的治疗方法。 最后,还提供了用于制备T细胞疫苗以及实施方案的试剂盒。

    Inactivated CD8+ T-cells for the treatment of HIV infection
    2.
    发明授权
    Inactivated CD8+ T-cells for the treatment of HIV infection 失效
    用于治疗HIV感染的灭活CD8 + T细胞

    公开(公告)号:US07740855B2

    公开(公告)日:2010-06-22

    申请号:US11290682

    申请日:2005-11-30

    IPC分类号: A61K39/00

    摘要: A method for the preparation of a T cell vaccine for the treatment of immunodeficient HIV-infected patients is described herein, based on the enrichment of autologous CD4-reactive CD8 T cells. Also described is a protocol for the implementation of T cell vaccination in immunodeficient HIV-infected, as well as a method of treatment, based on the T cell vaccine developed herein. Finally, kits for preparing the T cell vaccine as well as for implementing the protocol are also provided.

    摘要翻译: 基于自体CD4反应性CD8T细胞的富集,本文描述了用于制备用于治疗免疫缺陷型HIV感染患者的T细胞疫苗的方法。 还描述了用于在免疫缺陷型HIV感染中实施T细胞疫苗接种的方案,以及基于本文开发的T细胞疫苗的治疗方法。 最后,还提供了用于制备T细胞疫苗以及实施方案的试剂盒。

    Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
    3.
    发明申请
    Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases 审中-公开
    Hsp70衍生肽及其在自身免疫疾病诊断和治疗中的应用

    公开(公告)号:US20060089302A1

    公开(公告)日:2006-04-27

    申请号:US10505848

    申请日:2003-02-24

    摘要: The invention relates to specific peptides derived from hsp70, and to pharmaceutical compositions comprising the same. The peptides and compositions of the invention are particularly suitable for the prevention or treatment of an autoimmune disease such as Type 1 Diabetes, Systemic Lupus Erithematosus, Multiple Sclerosis or Rheumatoid Arthritis. The invention further relates to a method for diagnosing the occurrence or incipience of an autoimmune disease in a patient by use of the peptides of the invention, by testing a blood or urine sample of a patient for the presence of antibodies or T-cells which are immunologically reactive to human hsp70. The invention also relates to a kit for the diagnosis of an autoimmune disease by testing for the presence of anti-hsp70 antibodies by aid of the peptides of the invention.

    摘要翻译: 本发明涉及来源于hsp70的特异性肽以及包含其的药物组合物。 本发明的肽和组合物特别适用于预防或治疗自身免疫性疾病,例如1型糖尿病,系统性狼疮,多发性硬化或类风湿性关节炎。 本发明还涉及一种通过使用本发明的肽来诊断患者自身免疫性疾病的发生或发病的方法,通过测试患者的血液或尿液样品中是否存在抗体或T细胞 对人hsp70具有免疫反应性。 本发明还涉及一种用于诊断自身免疫性疾病的试剂盒,其通过借助本发明的肽测试抗hsp70抗体的存在来进行。

    T-CELL VACCINATION IN THE TREATMENT OF HIV INFECTION
    4.
    发明申请
    T-CELL VACCINATION IN THE TREATMENT OF HIV INFECTION 审中-公开
    T细胞疫苗治疗艾滋病毒感染

    公开(公告)号:US20100304483A1

    公开(公告)日:2010-12-02

    申请号:US12796971

    申请日:2010-06-09

    IPC分类号: C12N5/0783

    摘要: A method for the preparation of a T cell vaccine for the treatment of immunodeficient HIV-infected patients is described herein, based on the enrichment of autologous CD4-reactive CD8 T cells. Also described is a protocol for the implementation of T cell vaccination in immunodeficient HIV-infected, as well as a method of treatment, based on the T cell vaccine developed herein. Finally, kits for preparing the T cell vaccine as well as for implementing the protocol are also provided.

    摘要翻译: 基于自体CD4反应性CD8T细胞的富集,本文描述了用于制备用于治疗免疫缺陷型HIV感染患者的T细胞疫苗的方法。 还描述了用于在免疫缺陷型HIV感染中实施T细胞疫苗接种的方案,以及基于本文开发的T细胞疫苗的治疗方法。 最后,还提供了用于制备T细胞疫苗以及实施方案的试剂盒。